These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8598322)

  • 1. Growth inhibition by anti-estrogens and progestins in TGF-beta-resistant and -sensitive breast-tumor cells.
    Kalkhoven E; Beraldi E; Panno ML; De Winter JP; Thijssen JH; Van Der Burg B
    Int J Cancer; 1996 Mar; 65(5):682-7. PubMed ID: 8598322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of TGF-beta production in growth inhibition of breast-tumor cells by progestins.
    Kalkhoven E; Kwakkenbos-Isbrücker L; Mummery CL; de Laat SW; van den Eijnden-van Raaij AJ; van der Saag PT; van der Burg B
    Int J Cancer; 1995 Mar; 61(1):80-6. PubMed ID: 7705937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
    Herman ME; Katzenellenbogen BS
    Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines.
    Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G
    Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta.
    Arteaga CL; Koli KM; Dugger TC; Clarke R
    J Natl Cancer Inst; 1999 Jan; 91(1):46-53. PubMed ID: 9890169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor beta.
    Colletta AA; Wakefield LM; Howell FV; Danielpour D; Baum M; Sporn MB
    J Clin Invest; 1991 Jan; 87(1):277-83. PubMed ID: 1985102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells.
    Jeng MH; Langan-Fahey SM; Jordan VC
    Endocrinology; 1993 Jun; 132(6):2622-30. PubMed ID: 8504763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.
    Murphy LC; Dotzlaw H; Wong MS; Miller T; Murphy LJ
    Cancer Res; 1991 Apr; 51(8):2051-7. PubMed ID: 1849041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the growth-inhibitory effects of progestins and the antiestrogen hydroxyclomiphene on human breast cancer cells by epidermal growth factor and insulin.
    Koga M; Musgrove EA; Sutherland RL
    Cancer Res; 1989 Jan; 49(1):112-6. PubMed ID: 2642286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation.
    Jeng MH; Parker CJ; Jordan VC
    Cancer Res; 1992 Dec; 52(23):6539-46. PubMed ID: 1423300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-estrogen induced synthesis of transforming growth factor-beta in breast cancer patients.
    Mirza MR
    Cancer Treat Rev; 1991 Jun; 18(2):145-8. PubMed ID: 1804525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins.
    Gong Y; Anzai Y; Murphy LC; Ballejo G; Holinka CF; Gurpide E; Murphy LJ
    Cancer Res; 1991 Oct; 51(20):5476-81. PubMed ID: 1833051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth stimulation and differential regulation of transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, and TGF beta 3 messenger RNA levels by norethindrone in MCF-7 human breast cancer cells.
    Jeng MH; Jordan VC
    Mol Endocrinol; 1991 Aug; 5(8):1120-8. PubMed ID: 1834933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
    Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
    Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous growth factor expression in T-47D, human breast cancer cells, associated with reduced sensitivity to antiproliferative effects of progestins and antiestrogens.
    Murphy LC; Dotzlaw H
    Cancer Res; 1989 Feb; 49(3):599-604. PubMed ID: 2783382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines.
    Zugmaier G; Ennis BW; Deschauer B; Katz D; Knabbe C; Wilding G; Daly P; Lippman ME; Dickson RB
    J Cell Physiol; 1989 Nov; 141(2):353-61. PubMed ID: 2808542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of transforming growth factor alpha and transforming growth factor beta messenger ribonucleic acid abundance in T-47D, human breast cancer cells.
    Murphy LC; Dotzlaw H
    Mol Endocrinol; 1989 Apr; 3(4):611-7. PubMed ID: 2524651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of progestins, estrogens, and antihormones on growth and lactate dehydrogenase in the human breast cancer cell line T47D.
    Hissom JR; Bowden RT; Moore MR
    Endocrinology; 1989 Jul; 125(1):418-23. PubMed ID: 2737155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of colon and breast carcinoma cell growth by interleukin-4.
    Toi M; Bicknell R; Harris AL
    Cancer Res; 1992 Jan; 52(2):275-9. PubMed ID: 1728401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ; Jordan VC
    Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.